These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7937691)
1. Effects of cholecystokinin receptor antagonist loxiglumide on rat exocrine pancreas. Nakano S; Tachibana I; Otsuki M Pancreas; 1994 Jul; 9(4):425-33. PubMed ID: 7937691 [TBL] [Abstract][Full Text] [Related]
2. Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats. Imoto I; Yamamoto M; Jia DM; Otsuki M Int J Pancreatol; 1997 Dec; 22(3):177-85. PubMed ID: 9444548 [TBL] [Abstract][Full Text] [Related]
3. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats. Nakano S; Kihara Y; Otsuki M Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141 [TBL] [Abstract][Full Text] [Related]
4. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis. Nakano S; Tachibana I; Otsuki M Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770 [TBL] [Abstract][Full Text] [Related]
5. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats. Otsuki M; Nakano S; Tachibana I Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939 [TBL] [Abstract][Full Text] [Related]
6. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs. Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032 [TBL] [Abstract][Full Text] [Related]
7. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs. Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033 [TBL] [Abstract][Full Text] [Related]
8. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557 [TBL] [Abstract][Full Text] [Related]
9. Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion. Watanabe N; Otsuki M Int J Pancreatol; 1993 Apr; 13(2):129-37. PubMed ID: 8501354 [TBL] [Abstract][Full Text] [Related]
10. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats. Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923 [TBL] [Abstract][Full Text] [Related]
11. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A; Kulesza E; Konturek SJ Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088 [TBL] [Abstract][Full Text] [Related]
12. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]
13. A cholecystokinin receptor antagonist, loxiglumide, stimulates biliary secretion in conscious rats. Watanabe N; Otsuki M Eur J Pharmacol; 1994 Nov; 264(3):331-6. PubMed ID: 7698173 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs. Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion. Tanikawa M; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Kodaira T; Hamaoka T Arzneimittelforschung; 1993 Jan; 43(1):35-9. PubMed ID: 8447844 [TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide. Varga G; Papp M; Scarpignato C Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419 [TBL] [Abstract][Full Text] [Related]
18. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini]. Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851 [TBL] [Abstract][Full Text] [Related]
20. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat. Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G Digestion; 1991; 48(2):98-103. PubMed ID: 1868975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]